CCL2 and Alzheimer disease: AD patients had significantly elevated plasma levels of IL-1β, IL-6, TNF-α, and MCP-1 (<i>p</i> < 0.001), and decreased levels of IL-8 and IL-10 (<i>p</i> < 0.001).